Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Policies to relating to organ donation (H.R. 4583/4582 & S. 1552, the Living Donor Protection Act; H.R. 3698, the Living Organ Donor Tax Credit Act) and research into polycystic kidney disease (H.R. 9169, the PKD Cures Act).
To direct the Secretary of Defense to establish a pilot program regarding treating pregnancy as a qualifying event for enrollment in TRICARE Select.
Client: NATIONAL MILITARY FAMILY ASSOCIATION · Firm: CURA STRATEGIES
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
EVERY 100TH HEART via CURA STRATEGIES
2026 · third_quarter · Q3
Funding for CHD research and surveillance programs at the CDC and NIH.
Support for federal CHD research and surveillance programs at the NIH and CDC. Enforcement of the Congenital Heart Futures Reauthorization Act of 2024.
Source: Senate LDA
| EVERY 100TH HEART |
| 3 |
| 2026 |
Service member quality of life issues (Access to IVF coverage for military families through TRICARE; H.R. 7188/S. 3654, the Military Occupancy Living Defense (MOLD) Act; H.R. 4768/S. 2448, the Health Care Fairness for Military Families Act; H.R. 4381/S. 2239, Improving Access to Prenatal Care for Military Families Act; H.R. 6231/S. 3265, the Improve and Enhance the Work Opportunity Tax Credit Act).
Policies to relating to organ donation (H.R. 4583/4582 & S. 1552, the Living Donor Protection Act; H.R. 3698, the Living Organ Donor Tax Credit Act) and research into polycystic kidney disease (H.R. 9169, the PKD Cures Act).
Health Care Fairness for Military Families Act of 2025
Client: NATIONAL MILITARY FAMILY ASSOCIATION · Firm: CURA STRATEGIES
Service member quality of life issues (Access to IVF coverage for military families through TRICARE; H.R. 7188/S. 3654, the Military Occupancy Living Defense (MOLD) Act; H.R. 4768/S. 2448, the Health Care Fairness for Military Families Act; H.R. 4381/S. 2239, Improving Access to Prenatal Care for Military Families Act; H.R. 6231/S. 3265, the Improve and Enhance the Work Opportunity Tax Credit Act).
Improve and Enhance the Work Opportunity Tax Credit Act
Client: NATIONAL MILITARY FAMILY ASSOCIATION · Firm: CURA STRATEGIES
Service member quality of life issues (Access to IVF coverage for military families through TRICARE; H.R. 7188/S. 3654, the Military Occupancy Living Defense (MOLD) Act; H.R. 4768/S. 2448, the Health Care Fairness for Military Families Act; H.R. 4381/S. 2239, Improving Access to Prenatal Care for Military Families Act; H.R. 6231/S. 3265, the Improve and Enhance the Work Opportunity Tax Credit Act).
Service member quality of life issues (Access to IVF coverage for military families through TRICARE; H.R. 7188/S. 3654, the Military Occupancy Living Defense (MOLD) Act; H.R. 4768/S. 2448, the Health Care Fairness for Military Families Act; H.R. 4381/S. 2239, Improving Access to Prenatal Care for Military Families Act; H.R. 6231/S. 3265, the Improve and Enhance the Work Opportunity Tax Credit Act).
Policies to relating to organ donation (H.R. 4583/4582 & S. 1552, the Living Donor Protection Act; H.R. 3698, the Living Organ Donor Tax Credit Act) and research into polycystic kidney disease (H.R. 9169, the PKD Cures Act).
Policies to relating to organ donation (H.R. 4583/4582 & S. 1552, the Living Donor Protection Act; H.R. 3698, the Living Organ Donor Tax Credit Act) and research into polycystic kidney disease (H.R. 9169, the PKD Cures Act).
Improving Access to Prenatal Care for Military Families Act
Client: NATIONAL MILITARY FAMILY ASSOCIATION · Firm: CURA STRATEGIES
Service member quality of life issues (Access to IVF coverage for military families through TRICARE; H.R. 7188/S. 3654, the Military Occupancy Living Defense (MOLD) Act; H.R. 4768/S. 2448, the Health Care Fairness for Military Families Act; H.R. 4381/S. 2239, Improving Access to Prenatal Care for Military Families Act; H.R. 6231/S. 3265, the Improve and Enhance the Work Opportunity Tax Credit Act).
Health Care Fairness for Military Families Act of 2025
Client: NATIONAL MILITARY FAMILY ASSOCIATION · Firm: CURA STRATEGIES
Service member quality of life issues (Access to IVF coverage for military families through TRICARE; H.R. 7188/S. 3654, the Military Occupancy Living Defense (MOLD) Act; H.R. 4768/S. 2448, the Health Care Fairness for Military Families Act; H.R. 4381/S. 2239, Improving Access to Prenatal Care for Military Families Act; H.R. 6231/S. 3265, the Improve and Enhance the Work Opportunity Tax Credit Act).
Improve and Enhance the Work Opportunity Tax Credit Act
Client: NATIONAL MILITARY FAMILY ASSOCIATION · Firm: CURA STRATEGIES
Service member quality of life issues (Access to IVF coverage for military families through TRICARE; H.R. 7188/S. 3654, the Military Occupancy Living Defense (MOLD) Act; H.R. 4768/S. 2448, the Health Care Fairness for Military Families Act; H.R. 4381/S. 2239, Improving Access to Prenatal Care for Military Families Act; H.R. 6231/S. 3265, the Improve and Enhance the Work Opportunity Tax Credit Act).
Service member quality of life issues (Access to IVF coverage for military families through TRICARE; H.R. 7188/S. 3654, the Military Occupancy Living Defense (MOLD) Act; H.R. 4768/S. 2448, the Health Care Fairness for Military Families Act; H.R. 4381/S. 2239, Improving Access to Prenatal Care for Military Families Act; H.R. 6231/S. 3265, the Improve and Enhance the Work Opportunity Tax Credit Act).
Cardiovascular Advances in Research and Opportunities Legacy Act
Client: THE MENDED HEARTS, INC. · Firm: CURA STRATEGIES
Congressional passage of the CAROL Act (H.R. 1193/S. 1133) and the Newborn Screening Saves Lives Reauthorization Act of 2021 (H.R. 482/S. 350), continued and expanded federal funding for research into cardiovascular diseases and treatments
Cardiovascular Advances in Research and Opportunities Legacy Act
Client: THE MENDED HEARTS, INC. · Firm: CURA STRATEGIES
Congressional passage of the CAROL Act (H.R. 1193/S. 1133) and the Newborn Screening Saves Lives Reauthorization Act of 2021 (H.R. 482/S. 350), continued and expanded federal funding for research into cardiovascular diseases and treatments
Cardiovascular Advances in Research and Opportunities Legacy Act
Client: THE MENDED HEARTS, INC. · Firm: CURA STRATEGIES
Passage of the CAROL Act (H.R. 1193/S. 1133), passage of the Newborn Screening Saves Lives Reauthorization Act of 2021 (H.R. 482/S. 350), federal funding for cardiovascular disease research, introduction of legislation to address ACHD workforce shortages
Cardiovascular Advances in Research and Opportunities Legacy Act
Client: THE MENDED HEARTS, INC. · Firm: CURA STRATEGIES
Congressional passage of the CAROL Act (H.R. 1193/S. 1133) and the Newborn Screening Saves Lives Reauthorization Act of 2021 (H.R. 482/S. 350), continued and expanded federal funding for research into cardiovascular diseases and treatments
Newborn Screening Saves Lives Reauthorization Act of 2021
Client: THE MENDED HEARTS, INC. · Firm: CURA STRATEGIES
Congressional passage of the CAROL Act (H.R. 1193/S. 1133) and the Newborn Screening Saves Lives Reauthorization Act of 2021 (H.R. 482/S. 350), continued and expanded federal funding for research into cardiovascular diseases and treatments
Newborn Screening Saves Lives Reauthorization Act of 2021
Client: THE MENDED HEARTS, INC. · Firm: CURA STRATEGIES
Congressional passage of the CAROL Act (H.R. 1193/S. 1133) and the Newborn Screening Saves Lives Reauthorization Act of 2021 (H.R. 482/S. 350), continued and expanded federal funding for research into cardiovascular diseases and treatments
Newborn Screening Saves Lives Reauthorization Act of 2021
Client: THE MENDED HEARTS, INC. · Firm: CURA STRATEGIES
Passage of the CAROL Act (H.R. 1193/S. 1133), passage of the Newborn Screening Saves Lives Reauthorization Act of 2021 (H.R. 482/S. 350), federal funding for cardiovascular disease research, introduction of legislation to address ACHD workforce shortages
Newborn Screening Saves Lives Reauthorization Act of 2021
Client: THE MENDED HEARTS, INC. · Firm: CURA STRATEGIES
Congressional passage of the CAROL Act (H.R. 1193/S. 1133) and the Newborn Screening Saves Lives Reauthorization Act of 2021 (H.R. 482/S. 350), continued and expanded federal funding for research into cardiovascular diseases and treatments
Cardiovascular Advances in Research and Opportunities Legacy Act
Client: THE MENDED HEARTS, INC. · Firm: CURA STRATEGIES
Passage of the CAROL Act (H.R. 1193/S. 1133), passage of the Newborn Screening Saves Lives Reauthorization Act of 2021 (H.R. 482/S. 350), federal funding for cardiovascular disease research, introduction of legislation to address ACHD workforce shortages
Cardiovascular Advances in Research and Opportunities Legacy Act
Client: THE MENDED HEARTS, INC. · Firm: CURA STRATEGIES
Congressional passage of the CAROL Act (H.R. 1193/S. 1133) and the Newborn Screening Saves Lives Reauthorization Act of 2021 (H.R. 482/S. 350), continued and expanded federal funding for research into cardiovascular diseases and treatments
Cardiovascular Advances in Research and Opportunities Legacy Act
Client: THE MENDED HEARTS, INC. · Firm: CURA STRATEGIES
Congressional passage of the CAROL Act (H.R. 1193/S. 1133) and the Newborn Screening Saves Lives Reauthorization Act of 2021 (H.R. 482/S. 350), continued and expanded federal funding for research into cardiovascular diseases and treatments
Cardiovascular Advances in Research and Opportunities Legacy Act
Client: THE MENDED HEARTS, INC. · Firm: CURA STRATEGIES
Congressional passage of the CAROL Act (H.R. 1193/S. 1133) and the Newborn Screening Saves Lives Reauthorization Act of 2021 (H.R. 482/S. 350), continued and expanded federal funding for research into cardiovascular diseases and treatments
Newborn Screening Saves Lives Reauthorization Act of 2021
Client: THE MENDED HEARTS, INC. · Firm: CURA STRATEGIES
Congressional passage of the CAROL Act (H.R. 1193/S. 1133) and the Newborn Screening Saves Lives Reauthorization Act of 2021 (H.R. 482/S. 350), continued and expanded federal funding for research into cardiovascular diseases and treatments
Newborn Screening Saves Lives Reauthorization Act of 2021
Client: THE MENDED HEARTS, INC. · Firm: CURA STRATEGIES
Passage of the CAROL Act (H.R. 1193/S. 1133), passage of the Newborn Screening Saves Lives Reauthorization Act of 2021 (H.R. 482/S. 350), federal funding for cardiovascular disease research, introduction of legislation to address ACHD workforce shortages
Newborn Screening Saves Lives Reauthorization Act of 2021
Client: THE MENDED HEARTS, INC. · Firm: CURA STRATEGIES
Congressional passage of the CAROL Act (H.R. 1193/S. 1133) and the Newborn Screening Saves Lives Reauthorization Act of 2021 (H.R. 482/S. 350), continued and expanded federal funding for research into cardiovascular diseases and treatments
Newborn Screening Saves Lives Reauthorization Act of 2021
Client: THE MENDED HEARTS, INC. · Firm: CURA STRATEGIES
Congressional passage of the CAROL Act (H.R. 1193/S. 1133) and the Newborn Screening Saves Lives Reauthorization Act of 2021 (H.R. 482/S. 350), continued and expanded federal funding for research into cardiovascular diseases and treatments
Quality Care for Nursing Home Residents and Workers During COVID–19 and Beyond Act
Client: GLOBAL LIFE TECHNOLOGIES · Firm: CURA STRATEGIES
Appropriations as a topic area under the PRMRP. Recommending nasal decolonization for public use outside of the provider setting congressional passage of HR 953, HR 598/S317
Getting Americans Safely Back to Work Act of 2021
Client: GLOBAL LIFE TECHNOLOGIES · Firm: CURA STRATEGIES
Appropriations as a topic area under the PRMRP. Recommending nasal decolonization for public use outside of the provider setting congressional passage of HR 953, HR 598/S317
Quality Care for Nursing Home Residents and Workers During COVID–19 Act
Client: GLOBAL LIFE TECHNOLOGIES · Firm: CURA STRATEGIES
Appropriations as a topic area under the PRMRP. Recommending nasal decolonization for public use outside of the provider setting congressional passage of HR 953, HR 598/S317
Inclusion of CHD as a covered topic area under the Department of Defense's (DoD) Peer Reviewed Medical Research Program (PRMRP)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL MILITARY FAMILY ASSOCIATION via CURA STRATEGIES
2026 · third_quarter · Q3
Service member quality of life issues (Access to IVF coverage for military families through TRICARE; H.R. 7188/S. 3654, the Military Occupancy Living Defense (MOLD) Act; H.R. 4768/S. 2448, the Health Care Fairness for Military Families Act; H.R. 4381/S. 2239, Improving Access to Prenatal Care for Military Families Act; H.R. 6231/S. 3265, the Improve and Enhance the Work Opportunity Tax Credit Act).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADULT CONGENITAL HEART ASSOCIATION via CURA STRATEGIES
2026 · third_quarter · Q3
Federal funding for congenital heart disease research and surveillance at the Centers for Disease Control (CDC). Implementation of the Congenital Heart Futures Reauthorization Act of 2024.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
GLOBAL LIFE TECHNOLOGIES via CURA STRATEGIES
2026 · third_quarter · 3T
Consideration of alcohol based nasal decolonization tools.
Consideration of alcohol based nasal decolonization tools.
Consideration of alcohol based nasal decolonization tools.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
PKD FOUNDATION via CURA STRATEGIES
2026 · third_quarter · Q3
Policies to relating to organ donation (H.R. 4583/4582 & S. 1552, the Living Donor Protection Act; H.R. 3698, the Living Organ Donor Tax Credit Act) and research into polycystic kidney disease (H.R. 9169, the PKD Cures Act).
Inclusion of PKD as a covered topic area under the Department of Defense's Peer Reviewed Medical Research Program (PRMRP).
Federal funding for PKD research at the National Institutes of Health (NIH).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EVERY 100TH HEART via CURA STRATEGIES
2026 · second_quarter · Q2
Inclusion of CHD as a covered topic area under the Peer Reviewed Medical Research Program (PRMRP)
Support for federal CHD research and surveillance programs.
Funding for CHD research and surveillance programs at the CDC and NIH
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EVERY 100TH HEART via CURA STRATEGIES
2026 · second_quarter · RR
Federal support for congenital heart disease surveillance, workforce development, and research.
Federal support for congenital heart disease surveillance, workforce development, and research.
Federal support for congenital heart disease surveillance, workforce development, and research.
NATIONAL MILITARY FAMILY ASSOCIATION via CURA STRATEGIES
2026 · second_quarter · Q2
Service member quality of life issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADULT CONGENITAL HEART ASSOCIATION via CURA STRATEGIES
2026 · second_quarter · Q2
Congenital heart disease surveillance, research, and workforce development policies.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
GLOBAL LIFE TECHNOLOGIES via CURA STRATEGIES
2026 · second_quarter · Q2
Consideration of alcohol based nasal decolonization tools.
Consideration of alcohol based nasal decolonization tools.
Consideration of alcohol based nasal decolonization tools.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
PKD FOUNDATION via CURA STRATEGIES
2026 · second_quarter · Q2
Policies to relating to organ donation and research into polycystic kidney disease.
Inclusion of PKD as a covered topic area under the Peer Reviewed Medical Research Program.
Federal funding for PKD research.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL MILITARY FAMILY ASSOCIATION via CURA STRATEGIES
2026 · first_quarter · Q1
Service member quality of life issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADULT CONGENITAL HEART ASSOCIATION via CURA STRATEGIES
2026 · first_quarter · Q1
Congenital heart disease surveillance, research, and workforce development policies.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
GLOBAL LIFE TECHNOLOGIES via CURA STRATEGIES
2026 · first_quarter · Q1
Consideration of alcohol based nasal decolonization tools.
Consideration of alcohol based nasal decolonization tools.
Consideration of alcohol based nasal decolonization tools.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
PKD FOUNDATION via CURA STRATEGIES
2026 · first_quarter · Q1
Inclusion of PKD as a covered topic area under the Peer Reviewed Medical Research Program.
Federal funding for PKD research.
Policies to encourage organ donation.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL MILITARY FAMILY ASSOCIATION via CURA STRATEGIES
2025 · second_quarter · 2A
Service member quality of life issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL MILITARY FAMILY ASSOCIATION via CURA STRATEGIES
2025 · second_quarter · 2A
Service member quality of life issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PKD FOUNDATION via CURA STRATEGIES
2025 · second_quarter · 2A
Federal funding for PKD research.
Policies to encourage organ donation.
Inclusion of PKD as a covered topic area under the Peer Reviewed Medical Research Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PKD FOUNDATION via CURA STRATEGIES
2025 · second_quarter · 2A
Federal funding for PKD research.
Policies to encourage organ donation.
Inclusion of PKD as a covered topic area under the Peer Reviewed Medical Research Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL MILITARY FAMILY ASSOCIATION via CURA STRATEGIES
2025 · fourth_quarter · Q4
Service member quality of life issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADULT CONGENITAL HEART ASSOCIATION via CURA STRATEGIES
2025 · fourth_quarter · Q4
Congenital heart disease surveillance, research, and workforce development policies.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
GLOBAL LIFE TECHNOLOGIES via CURA STRATEGIES
2025 · fourth_quarter · Q4
Consideration of alcohol based nasal decolonization tools.
Consideration of alcohol based nasal decolonization tools.
Consideration of alcohol based nasal decolonization tools.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
PKD FOUNDATION via CURA STRATEGIES
2025 · fourth_quarter · Q4
Federal funding for PKD research.
Policies to encourage organ donation.
Inclusion of PKD as a covered topic area under the Peer Reviewed Medical Research Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · third_quarter · 3T
Living organ donation policies and coverage for innovative transplant diagnostics
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL MILITARY FAMILY ASSOCIATION via CURA STRATEGIES
2025 · third_quarter · Q3
Service member quality of life issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADULT CONGENITAL HEART ASSOCIATION via CURA STRATEGIES
2025 · third_quarter · Q3
Congenital heart disease surveillance, research, and workforce development policies.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
GLOBAL LIFE TECHNOLOGIES via CURA STRATEGIES
2025 · third_quarter · Q3
Consideration of alcohol based nasal decolonization tools.
Consideration of alcohol based nasal decolonization tools.
Consideration of alcohol based nasal decolonization tools.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
PKD FOUNDATION via CURA STRATEGIES
2025 · third_quarter · Q3
Federal funding for PKD research.
Policies to encourage organ donation.
Inclusion of PKD as a covered topic area under the Peer Reviewed Medical Research Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL MILITARY FAMILY ASSOCIATION via CURA STRATEGIES
2025 · second_quarter · Q2
Service member quality of life issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLOBAL LIFE TECHNOLOGIES via CURA STRATEGIES
2025 · second_quarter · Q2
Consideration of alcohol based nasal decolonization tools.
Consideration of alcohol based nasal decolonization tools.
Consideration of alcohol based nasal decolonization tools.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
PKD FOUNDATION via CURA STRATEGIES
2025 · second_quarter · Q2
Federal funding for PKD research.
Policies to encourage organ donation.
Inclusion of PKD as a covered topic area under the Peer Reviewed Medical Research Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADULT CONGENITAL HEART ASSOCIATION via CURA STRATEGIES
2025 · second_quarter · Q2
Congenital heart disease surveillance, research, and workforce development policies.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL MILITARY FAMILY ASSOCIATION via CURA STRATEGIES
2025 · first_quarter · Q1
Service member quality of life issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLOBAL LIFE TECHNOLOGIES via CURA STRATEGIES
2025 · first_quarter · Q1
Consideration of alcohol based nasal decolonization tools.
Consideration of alcohol based nasal decolonization tools.
Consideration of alcohol based nasal decolonization tools.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
PKD FOUNDATION via CURA STRATEGIES
2025 · first_quarter · Q1
Federal funding for PKD research.
Policies to encourage organ donation.
Inclusion of PKD as a covered topic area under the Peer Reviewed Medical Research Program.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADULT CONGENITAL HEART ASSOCIATION via CURA STRATEGIES
2025 · first_quarter · Q1
Congenital heart disease surveillance, research, and workforce development policies.
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
ADULT CONGENITAL HEART ASSOCIATION via CURA STRATEGIES
2024 · fourth_quarter · Q4
Workforce development for Adult Congenital Heart Defect (ACHD) care providers, reauthorization of CHD programs at CDC, ACHD research funding
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL MILITARY FAMILY ASSOCIATION via CURA STRATEGIES
2024 · fourth_quarter · Q4
Servicemember quality-of-life provisions
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLOBAL LIFE TECHNOLOGIES via CURA STRATEGIES
2024 · fourth_quarter · Q4
Establishment of a pilot study to assess the effectiveness of a daily application of clinically-proven alcohol-based nasal antiseptic in reducing infection risk and enhancing warfighter operational readiness.
Establishment of a pilot study to assess the effectiveness of a daily application of clinically-proven alcohol-based nasal antiseptic in reducing infection risk and enhancing warfighter operational readiness.
Establishment of a pilot study to assess the effectiveness of a daily application of clinically-proven alcohol-based nasal antiseptic in reducing infection risk and enhancing warfighter operational readiness.
PKD FOUNDATION via CURA STRATEGIES
2024 · fourth_quarter · Q4
Inclusion of PKD as a covered issue area under the Peer Review Medical Research Program (PRMRP)
Report language commending NIH/NIDDK for funding PKD research, urging the CDC to dedicate Chronic Kidney Disease funding to inherited diseases, such as PKD
Passage of the Living Donor Protection Act, introduction of legislation which would elevate and address racial disparities in kidney and transplant carer, and passage of the Living Organ Donor Tax Credit Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Q4
Medicare/Insurance coverage for innovative diagnostic testing
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL MILITARY FAMILY ASSOCIATION via CURA STRATEGIES
2024 · fourth_quarter · RR
Servicemember quality-of-life provisions
ADULT CONGENITAL HEART ASSOCIATION via CURA STRATEGIES
2024 · third_quarter · Q3
Workforce development for Adult Congenital Heart Defect (ACHD) care providers, reauthorization of CHD programs at CDC, ACHD research funding
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
GLOBAL LIFE TECHNOLOGIES via CURA STRATEGIES
2024 · third_quarter · Q3
Establishment of a pilot study to assess the effectiveness of a daily application of clinically-proven alcohol-based nasal antiseptic in reducing infection risk and enhancing warfighter operational readiness.
Establishment of a pilot study to assess the effectiveness of a daily application of clinically-proven alcohol-based nasal antiseptic in reducing infection risk and enhancing warfighter operational readiness.
Establishment of a pilot study to assess the effectiveness of a daily application of clinically-proven alcohol-based nasal antiseptic in reducing infection risk and enhancing warfighter operational readiness.
PKD FOUNDATION via CURA STRATEGIES
2024 · third_quarter · Q3
Passage of the Living Donor Protection Act, introduction of legislation which would elevate and address racial disparities in kidney and transplant carer, and passage of the Living Organ Donor Tax Credit Act
Inclusion of PKD as a covered issue area under the Peer Review Medical Research Program (PRMRP)
Report language commending NIH/NIDDK for funding PKD research, urging the CDC to dedicate Chronic Kidney Disease funding to inherited diseases, such as PKD
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Q3
Medicare/Insurance coverage for innovative diagnostic testing
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2024 · second_quarter · Q2
Medicare/Insurance coverage for innovative diagnostic testing
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PKD FOUNDATION via CURA STRATEGIES
2024 · second_quarter · Q2
Inclusion of PKD as a covered issue area under the Peer Review Medical Research Program (PRMRP)
Report language commending NIH/NIDDK for funding PKD research, urging the CDC to dedicate Chronic Kidney Disease funding to inherited diseases, such as PKD
Passage of the Living Donor Protection Act, introduction of legislation which would elevate and address racial disparities in kidney and transplant carer, and passage of the Living Organ Donor Tax Credit Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLOBAL LIFE TECHNOLOGIES via CURA STRATEGIES
2024 · second_quarter · Q2
Establishment of a pilot study to assess the effectiveness of a daily application of clinically-proven alcohol-based nasal antiseptic in reducing infection risk and enhancing warfighter operational readiness.
Establishment of a pilot study to assess the effectiveness of a daily application of clinically-proven alcohol-based nasal antiseptic in reducing infection risk and enhancing warfighter operational readiness.
Establishment of a pilot study to assess the effectiveness of a daily application of clinically-proven alcohol-based nasal antiseptic in reducing infection risk and enhancing warfighter operational readiness.
ADULT CONGENITAL HEART ASSOCIATION via CURA STRATEGIES
2024 · second_quarter · Q2
Workforce development for Adult Congenital Heart Defect (ACHD) care providers, reauthorization of CHD programs at CDC, ACHD research funding
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
THE MENDED HEARTS, INC. via CURA STRATEGIES
2024 · first_quarter · 1T
Passage of the Access to AEDs Act, potential Peer Support research legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADULT CONGENITAL HEART ASSOCIATION via CURA STRATEGIES
2024 · first_quarter · Q1
Workforce development for Adult Congenital Heart Defect (ACHD) care providers, reauthorization of CHD programs at CDC, ACHD research funding
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
GLOBAL LIFE TECHNOLOGIES via CURA STRATEGIES
2024 · first_quarter · Q1
Establishment of a pilot study to assess the effectiveness of a daily application of clinically-proven alcohol-based nasal antiseptic in reducing infection risk and enhancing warfighter operational readiness.
Establishment of a pilot study to assess the effectiveness of a daily application of clinically-proven alcohol-based nasal antiseptic in reducing infection risk and enhancing warfighter operational readiness.
Establishment of a pilot study to assess the effectiveness of a daily application of clinically-proven alcohol-based nasal antiseptic in reducing infection risk and enhancing warfighter operational readiness.
PKD FOUNDATION via CURA STRATEGIES
2024 · first_quarter · Q1
Passage of the Living Donor Protection Act, introduction of legislation which would elevate and address racial disparities in kidney and transplant carer, and passage of the Living Organ Donor Tax Credit Act
Inclusion of PKD as a covered issue area under the Peer Review Medical Research Program (PRMRP)
Report language commending NIH/NIDDK for funding PKD research, urging the CDC to dedicate Chronic Kidney Disease funding to inherited diseases, such as PKD
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · first_quarter · Q1
Medicare/Insurance coverage for innovative diagnostic testing
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE MENDED HEARTS, INC. via CURA STRATEGIES
2023 · fourth_quarter · Q4
Passage of the Access to AEDs Act, potential Peer Support research legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADULT CONGENITAL HEART ASSOCIATION via CURA STRATEGIES
2023 · fourth_quarter · Q4
Workforce development for Adult Congenital Heart Defect (ACHD) care providers, reauthorization of CHD programs at CDC, ACHD research funding
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
GLOBAL LIFE TECHNOLOGIES via CURA STRATEGIES
2023 · fourth_quarter · Q4
Establishment of a pilot study to assess the effectiveness of a daily application of clinically-proven alcohol-based nasal antiseptic in reducing infection risk and enhancing warfighter operational readiness.
Establishment of a pilot study to assess the effectiveness of a daily application of clinically-proven alcohol-based nasal antiseptic in reducing infection risk and enhancing warfighter operational readiness.
Establishment of a pilot study to assess the effectiveness of a daily application of clinically-proven alcohol-based nasal antiseptic in reducing infection risk and enhancing warfighter operational readiness.
PKD FOUNDATION via CURA STRATEGIES
2023 · fourth_quarter · Q4
Passage of the Living Donor Protection Act, introduction of legislation which would elevate and address racial disparities in kidney and transplant carer
Inclusion of PKD as a covered issue area under the Peer Review Medical Research Program (PRMRP)
Report language commending NIH/NIDDK for funding PKD research, urging the CDC to dedicate Chronic Kidney Disease funding to inherited diseases, such as PKD
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · fourth_quarter · Q4
Medicare/Insurance coverage for innovative diagnostic testing
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE MENDED HEARTS, INC. via CURA STRATEGIES
2023 · third_quarter · Q3
Passage of the Access to AEDs Act, potential Peer Support research legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADULT CONGENITAL HEART ASSOCIATION via CURA STRATEGIES
2023 · third_quarter · Q3
Workforce development for Adult Congenital Heart Defect (ACHD) care providers, reauthorization of CHD programs at CDC, ACHD research funding
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
GLOBAL LIFE TECHNOLOGIES via CURA STRATEGIES
2023 · third_quarter · Q3
Establishment of a pilot study to assess the effectiveness of a daily application of clinically-proven alcohol-based nasal antiseptic in reducing infection risk and enhancing warfighter operational readiness.
Establishment of a pilot study to assess the effectiveness of a daily application of clinically-proven alcohol-based nasal antiseptic in reducing infection risk and enhancing warfighter operational readiness.
Establishment of a pilot study to assess the effectiveness of a daily application of clinically-proven alcohol-based nasal antiseptic in reducing infection risk and enhancing warfighter operational readiness.
PKD FOUNDATION via CURA STRATEGIES
2023 · third_quarter · Q3
Passage of the Living Donor Protection Act, introduction of legislation which would elevate and address racial disparities in kidney and transplant carer
Report language commending NIH/NIDDK for funding PKD research, urging the CDC to dedicate Chronic Kidney Disease funding to inherited diseases, such as PKD
Inclusion of PKD as a covered issue area under the Peer Review Medical Research Program (PRMRP)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · third_quarter · Q3
Medicare/Insurance coverage for innovative diagnostic testing
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE MENDED HEARTS, INC. via CURA STRATEGIES
2023 · second_quarter · Q2
Passage of the Access to AEDs Act, potential Peer Support research legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADULT CONGENITAL HEART ASSOCIATION via CURA STRATEGIES
2023 · second_quarter · Q2
Workforce development for Adult Congenital Heart Defect (ACHD) care providers, reauthorization of CHD programs at CDC, ACHD research funding
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
GLOBAL LIFE TECHNOLOGIES via CURA STRATEGIES
2023 · second_quarter · Q2
Establishment of a pilot study to assess the effectiveness of a daily application of clinically-proven alcohol-based nasal antiseptic in reducing infection risk and enhancing warfighter operational readiness.
Establishment of a pilot study to assess the effectiveness of a daily application of clinically-proven alcohol-based nasal antiseptic in reducing infection risk and enhancing warfighter operational readiness.
Establishment of a pilot study to assess the effectiveness of a daily application of clinically-proven alcohol-based nasal antiseptic in reducing infection risk and enhancing warfighter operational readiness.
PKD FOUNDATION via CURA STRATEGIES
2023 · second_quarter · Q2
Inclusion of PKD as a covered issue area under the Peer Review Medical Research Program (PRMRP)
Report language commending NIH/NIDDK for funding PKD research, urging the CDC to dedicate Chronic Kidney Disease funding to inherited diseases, such as PKD
Passage of the Living Donor Protection Act, introduction of legislation which would elevate and address racial disparities in kidney and transplant carer
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · second_quarter · Q2
Medicare/Insurance coverage for innovative diagnostic testing
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ADULT CONGENITAL HEART ASSOCIATION via CURA STRATEGIES
2023 · first_quarter · Q1
Workforce development for Adult Congenital Heart Defect (ACHD) care providers, reauthorization of CHD programs at CDC, ACHD research funding
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
THE MENDED HEARTS, INC. via CURA STRATEGIES
2023 · first_quarter · Q1
Passage of the Access to AEDs Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLOBAL LIFE TECHNOLOGIES via CURA STRATEGIES
2023 · first_quarter · Q1
Establishment of a pilot study to assess the effectiveness of a daily application of clinically-proven alcohol-based nasal antiseptic in reducing infection risk and enhancing warfighter operational readiness.
Establishment of a pilot study to assess the effectiveness of a daily application of clinically-proven alcohol-based nasal antiseptic in reducing infection risk and enhancing warfighter operational readiness.
Establishment of a pilot study to assess the effectiveness of a daily application of clinically-proven alcohol-based nasal antiseptic in reducing infection risk and enhancing warfighter operational readiness.
PKD FOUNDATION via CURA STRATEGIES
2023 · first_quarter · Q1
Passage of the Living Donor Protection Act, introduction of legislation which would elevate and address racial disparities in kidney and transplant carer
Inclusion of PKD as a covered issue area under the Peer Review Medical Research Program (PRMRP)
Report language commending NIH/NIDDK for funding PKD research, urging the CDC to dedicate Chronic Kidney Disease funding to inherited diseases, such as PKD
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE MENDED HEARTS, INC. via CURA STRATEGIES
2022 · fourth_quarter · Q4
Congressional passage of the CAROL Act (H.R. 1193/S. 1133) and the Newborn Screening Saves Lives Reauthorization Act of 2021 (H.R. 482/S. 350), continued and expanded federal funding for research into cardiovascular diseases and treatments
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADULT CONGENITAL HEART ASSOCIATION via CURA STRATEGIES
2022 · fourth_quarter · Q4
Adult Congenital Heart Disease workforce development legislation, federal funding for CHD research
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
PKD FOUNDATION via CURA STRATEGIES
2022 · fourth_quarter · Q4
Inclusion of polycystic kidney disease as a topic area of the PRMRP
Inclusion of polycystic kidney disease as a topic area of the PRMRP, introduction of racial disparities in transplant/kidney care legislation, passage of the Living Donor Protection Act
Inclusion of polycystic kidney disease as a topic area of the PRMRP. Support for the Living Donor Protection Act, introduction of racial disparities in transplant care legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PKD FOUNDATION via CURA STRATEGIES
2022 · third_quarter · Q3
Inclusion of polycystic kidney disease as a topic area of the PRMRP, introduction of racial disparities in transplant/kidney care legislation, passage of the Living Donor Protection Act
Inclusion of polycystic kidney disease as a topic area of the PRMRP. Support for the Living Donor Protection Act, introduction of racial disparities in transplant care legislation
Inclusion of polycystic kidney disease as a topic area of the PRMRP
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE MENDED HEARTS, INC. via CURA STRATEGIES
2022 · third_quarter · Q3
Congressional passage of the CAROL Act (H.R. 1193/S. 1133) and the Newborn Screening Saves Lives Reauthorization Act of 2021 (H.R. 482/S. 350), continued and expanded federal funding for research into cardiovascular diseases and treatments
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ADULT CONGENITAL HEART ASSOCIATION via CURA STRATEGIES
2022 · third_quarter · Q3
Adult Congenital Heart Disease workforce development legislation, federal funding for CHD research
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
THE MENDED HEARTS, INC. via CURA STRATEGIES
2022 · second_quarter · Q2
Congressional passage of the CAROL Act (H.R. 1193/S. 1133) and the Newborn Screening Saves Lives Reauthorization Act of 2021 (H.R. 482/S. 350), continued and expanded federal funding for research into cardiovascular diseases and treatments
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE MENDED HEARTS, INC. via CURA STRATEGIES
2022 · second_quarter · RR
Passage of the CAROL Act (H.R. 1193/S. 1133), passage of the Newborn Screening Saves Lives Reauthorization Act of 2021 (H.R. 482/S. 350), federal funding for cardiovascular disease research, introduction of legislation to address ACHD workforce shortages
PKD FOUNDATION via CURA STRATEGIES
2022 · second_quarter · Q2
Inclusion of polycystic kidney disease as a topic area of the PRMRP. Support for the Living Donor Protection Act, introduction of racial disparities in transplant care legislation
Inclusion of polycystic kidney disease as a topic area of the PRMRP, introduction of racial disparities in transplant/kidney care legislation, passage of the Living Donor Protection Act
Inclusion of polycystic kidney disease as a topic area of the PRMRP
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PKD FOUNDATION via CURA STRATEGIES
2022 · first_quarter · Q1
Inclusion of polycystic kidney disease as a topic area of the PRMRP
Inclusion of polycystic kidney disease as a topic area of the PRMRP, introduction of racial disparities in transplant/kidney care legislation, passage of the Living Donor Protection Act
Inclusion of polycystic kidney disease as a topic area of the PRMRP. Support for the Living Donor Protection Act, introduction of racial disparities in transplant care legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PKD FOUNDATION via CURA STRATEGIES
2021 · fourth_quarter · Q4
Inclusion of polycystic kidney disease as a topic area of the PRMRP, introduction of racial disparities in transplant/kidney care legislation, passage of the Living Donor Protection Act
Inclusion of polycystic kidney disease as a topic area of the PRMRP
Inclusion of polycystic kidney disease as a topic area of the PRMRP. Support for the Living Donor Protection Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GLOBAL LIFE TECHNOLOGIES via CURA STRATEGIES
2021 · third_quarter · Q3
Appropriations as a topic area under the PRMRP. Recommending nasal decolonization for public use outside of the provider setting congressional passage of HR 953, HR 598/S317
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
PKD FOUNDATION via CURA STRATEGIES
2021 · third_quarter · Q3
Inclusion of polycystic kidney disease as a topic area of the PRMRP. Support for the Living Donor Protection Act
Inclusion of polycystic kidney disease as a topic area of the PRMRP
Inclusion of polycystic kidney disease as a topic area of the PRMRP
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE